In the BioHarmony Drug Report Database
Enalapril
Epaned, Vasotec (enalapril) is a small molecule pharmaceutical. Enalapril was first approved as Epaned on 1985-12-24. It is used to treat bartter syndrome, diabetic nephropathies, edema, heart failure, and left ventricular dysfunction amongst others in the USA. The pharmaceutical is active against angiotensin-converting enzyme. Vasotec’s patents are valid until 2036-03-25 (FDA).
Trade Name
|
Epaned, Vasotec |
|---|---|
Common Name
|
enalapril |
ChEMBL ID
|
CHEMBL578 |
Indication
|
bartter syndrome, diabetic nephropathies, edema, heart failure, left ventricular dysfunction, malignant hypertension, rheumatoid arthritis |
Drug Class
|
Narcotic agonists/antagonists (normorphine type); antihypertensives (ACE inhibitors) |
Image (chem structure or protein)